This inventor holds 2 USPTO granted patents. Top assignee: Id Biomedical Corporation of Quebec. Active years: 2004-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2008
Title: Martin Plante: Innovator in Vaccine Development
Introduction
Martin Plante is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of vaccine development, particularly in the area of influenza vaccines. With a total of 2 patents, his work has the potential to impact public health positively.
Latest Patents
One of Martin Plante's latest patents is focused on the Proteosome influenza vaccine. This patent describes improved forms of vaccines that comprise proteosomes and protein antigens. Vaccines containing influenza HA as the antigen are used to illustrate the efficacy of these improvements. The patent also includes enhancements in the preparation of the vaccines themselves and the proteosome component.
Career Highlights
Martin Plante is currently associated with Id Biomedical Corporation of Quebec, where he continues to innovate in the field of vaccine technology. His work is characterized by a commitment to improving vaccine efficacy and safety.
Collaborations
Throughout his career, Martin has collaborated with notable colleagues, including David S. Burt and David Hugh Jones. These collaborations have further enriched his research and development efforts.
Conclusion
Martin Plante's contributions to vaccine development, particularly through his innovative patents, highlight his role as a key figure in the field. His work continues to pave the way for advancements in public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile